About PTC Therapeutics
Founded in 1998, PTC is a global commercial, diversified biopharmaceutical company. At PTC, we are committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones.
PTC supports the rare disease community and Rare Disease Day each year through a series of awareness and educational activities including social media, Rare Disease Day events and initiatives organised by our teams across the globe. Some of our programs and initiatives include
#DuchenneCan (www.duchennecan.com) a global campaign highlighting what people with Duchenne CAN do. It brings together stories of individuals in the community whose abilities, strengths and determination have inspired personal growth and progress, positive change in the community and amplified the voice of Duchenne globally. Follow #DuchenneCan on social media.
Duchenne And You (www.duchenneandyou.eu) a disease awareness websites and a resource dedicated to those who have had their lives touched by Duchenne muscular dystrophy (DMD).
About AADC (aboutaadc.eu) a disease awareness website and resource dedicated to those who are affected by aromatic L-amino acid decarboxylase (AADC) deficiency. The website provides information and a number of useful resources including podcasts with insights from medical experts and caregivers as they discuss their own experiences of AADC deficiency.
STRIVE Awards (www.ptcstriveawards.com) is an annual PTC grant awards program that recognizes and supports nonprofit organizations committed to serving rare disease communities. Each year application window opens in February and in September the award recipients are announced.
Images
